Abstract
dc:descriptionHuman hematological malignancies and leukemias in particular are characterized by genetic aberrations, like germline and acquired mutations, epigenetic events and acquired recurring chromosomal abnormalities. One of the most well studied genes associated to myeloid neoplasms is RUNX1. Additionally, numerous studies have provided evidence regarding the importance of the BCOR gene in physiological hematopoiesis with mutations of this gene in knockout organisms resulting in hematological abnormalities. Here we characterized a previously unknown acquired translocation, namely t(X;21)(p11.4;q22.12), occurring in both Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML), thus likely affecting an hematopoietic stem cell or an early progenitor. Unexpectedly the result of juxtaposition was not a fusion gene. Instead, the major molecular consequences were co-deletions of both BCOR and RUNX1 genes. Thus the reciprocal translocation t(X;21) represents an unusual chromosome aberration in MDS/AML leading to deletion of two entire genes. Functional studies are necessary to understand the effect of this primary cytogenetic event and its role in the stepwise pathogenesis of the malignant process that is characterized by a genomic landscape marked by epigenetic mechanisms. At the same time later studies reveal the importance of better understanding the association between immunological and malignant disorders. To that end, the Indoleamine 2,3-dioxygenase 1 (IDO1) that belongs to the class of inhibitory immune checkpoint molecules, seems to be of great interest. Such regulators of the immune system are crucial for maintaining self-tolerance and thus, when properly working, preventing autoimmunity. Many genetic alterations of IDO1 have been proposed to be related with dysimmune disorders and interestingly enough to cancer. By decoding the functional rs751360195 SNV, our study pinpoints IDO1 as potential biomarker of dysimmune disorders but also contributing to the malignant phenotype. Our identification of IDO1 variants at the coding sequence suggests a role in both immunological and malignant disorders, including those emerging in cases with germline DDX41 mutation. The increased interest for a causal association of genetic variations -copy number variations, translocations, mutations- with clinical phenotype has contributed to precise diagnosis and tailored therapeutic treatments of diseases.
Degree
thesis:*- Grantor dc:publisher
- Institutes outside Greece
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mavridou, Elena-Eleni
- Μαυρίδου, Έλενα-Ελένη
Subjects
dc:subject × 14- Μυελοδυσπλαστικά σύνδρομα (MDS)
- Λευχαιμία, Οξεία μυελογενής
- Μεταλλάξεις / Πολυμορφισμοί γονιδίων
- ΚΥΤΤΑΡΟΓΕΝΕΤΙΚΕΣ ΑΝΩΜΑΛΙΕΣ-ΧΡΩΜΟΣΩΜΙΚΕΣ ΜΕΛΕΤΕΣ
- Myelodyoplastic syndromes (MDS)
- Acute myeloid leukemia - AML
- Gene mutations / Polymorphisms
- CYTOGENETICS ABNORMALITIES-CROMOSOME-STUDIES
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Γενετική ανθρώπου
- Basic Medicine
- Medical and Health Sciences
- Human genetics
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/53445